Understanding the noradrenergic system in aging and Parkinson’s

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a novel radiotracer that targets alpha2C-adrenergic receptors to visualize the noradrenergic system in humans. Participants include healthy adults aged 20–80 and individuals with idiopathic, levodopa-sensitive Parkinson’s disease aged 40–80. Scanning combines PET with MRI, followed by neuropsychological testing and olfactory screening to explore links between neurochemistry and function. The goal is to identify age- and disease-related changes in the noradrenergic system and their associations with neurobehavioral performance.

Why it matters

Who can join: the full rules

Inclusion Criteria for the healthy controls:

* Age between 20 years and 80 years
* Weight between 40kg and 100kg
* Without neurologic or psychiatric history
* Without head trauma history including loss of consciousness superior to 30 minutes.
* With highly effective contraception for women of childbearing age
* Affiliated to a social security or similar scheme
* Not subject to any legal protection measures
* Participant must have signed an informed consent document

Inclusion Criteria for the patients with Parkinson's disease:

* Age between 40 years and 80 years
* Weight between 40kg and 100kg
* With an idiopathic Parkinson's disease (Dopa-sensitive)
* Without head trauma history including loss of consciousness superior to 30 minutes.
* Without associated neurological pathology
* With highly effective contraception for women of childbearing age
* Affiliated to a social security or similar scheme
* Not subject to any legal protection measures
* Participant must have signed an informed consent document

Exclusion Criteria for all participants :

* Subject receiving (or having received in the last month) somatic medication with cerebral or psychological effects (e.g., antihistamines), see list in Appendix1
* Subjects with a current or past dependence on alcohol or any other addictive substance according to DSM-IV-TR criteria, with the exception of nicotine and caffeine; -
* Subjects already participating in another biomedical research project or who have participated in a study using ionizing radiation within the past year;
* Pregnant woman parturient or breastfeeding
* MRI contraindications (: people using pacemaker or insulin pumps, with implanted or embedded metal objects in the head or body, claustrophobic, with neurosensory stimulators or implantable defibrillators, with cochlear implants, with ferromagnetic foreign bodies in the eye or brain close to nerve structures, agitation of the subject (uncooperative or agitated subjects), ventriculoperitoneal neurosurgical shunt valves, dental appliances)
* Subject with a contraindication to PET scans at the ORM: hypersensitivity to the active substance or to any of the excipients (sodium chloride)
* Subjects who are unable to understand or complete the study (language barrier, obvious lack of motivation, etc.) as judged by the investigator.
* Subjects who do not agree to be informed in the event of an incidental finding of an abnormality on MRI or during neuropsychological assessment.
* Persons deprived of their liberty by judicial or administrative decision.
* Persons receiving psychiatric care.
* Persons admitted to a health or social care facility for purposes other than research.

Where it's running

• Hôpital Neurologique Pierre Wertheimer - Service de Neurologie
  Bron, France Recruiting

Study contacts

• Study coordinator: Chloé Laurencin, MD / PhD
• Email: chloe.laurencin@chu-lyon.fr
• Phone: 472118022

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood viscosity in ARDS: a look at how thick the blood is

  This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07823296

• Virus interactions in hospitalized patients during winter seasons in Lyon

  This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.

  Recruiting Hospices Civils de Lyon · Lyon, Rhone · NCT07805590

• Surgical Use of Efanoctocog alfa in Hemophilia A Patients

  This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.

  Recruiting Hospices Civils de Lyon · Bron · NCT07723560

• Sleep quality and its determinants during the liver transplant pathway

  This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07674355

• Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs

  This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.

  Recruiting at 2 sites Hospices Civils de Lyon · Lyon and 1 other locations · NCT07643454

• French version validation of the New Mobility Score for older adults after hip fracture

  This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07622095

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.